Drug Profile
Research programme: kinase inhibitors - Genentech
Alternative Names: Kinase inhibitors research programme - GenentechLatest Information Update: 25 Aug 2009
Price :
$50
*
At a glance
- Originator Genentech
- Class Small molecules
- Mechanism of Action Phosphotransferase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 25 Aug 2009 Discontinued - Preclinical for Cancer in USA (unspecified route)
- 15 Jan 2007 Amphora Discovery Corporation sells its entire oncology research programme to Genentech
- 05 May 2005 Data presented at the 96th Annual Meeting of the American Association for Cancer Research (AACR-2005) have been added to the Cancer pharmacodynamics section